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AbstrACt
Objective We reviewed cohort studies to determine the 
magnitude and temporal direction of the association 
between recent intimate partner violence (IPV) and a range 
of adverse health outcomes or health risk behaviours.
Design Systematic review and meta-analysis.
Methods Medline, EMBASE and PsycINFO were searched 
from the first record to November 2016. Recent IPV was 
defined as occurring up to and including the last 12 
months; all health outcomes were eligible for inclusion. 
Results were combined using random-effects meta-
analysis.
results 35 separate cohort studies were retrieved. Eight 
studies showed evidence of a positive association between 
recent IPV and subsequent depressive symptoms, with 
a pooled OR from five estimates of 1.76 (95% CI 1.26 
to 2.44, I2=37.5%, p=0.172). Five studies demonstrated 
a positive, statistically significant relationship between 
depressive symptoms and subsequent IPV; the pooled OR 
from two studies was 1.72 (95% CI 1.28 to 2.31, I2=0.0%, 
p=0.752). Recent IPV was also associated with increased 
symptoms of subsequent postpartum depression in five 
studies (OR=2.19, 95% CI 1.39 to 3.45, p=0.000), although 
there was substantial heterogeneity. There was some 
evidence of a bidirectional relationship between recent IPV 
and hard drug use and marijuana use, although studies 
were limited. There was no evidence of an association 
between recent IPV and alcohol use or sexually transmitted 
infections (STIs), although there were few studies and 
inconsistent measurement of alcohol and STIs.
Conclusions Exposure to violence has significant 
impacts. Longitudinal studies are needed to understand 
the temporal relationship between recent IPV and 
different health issues, while considering the differential 
effects of recent versus past exposure to IPV. Improved 
measurement will enable an understanding of the 
immediate and longer term health needs of women 
exposed to IPV. Healthcare providers and IPV organisations 
should be aware of the bidirectional relationship between 
recent IPV and depressive symptoms.
PrOsPErO registration number CRD42016033372.
bACkgrOunD  
Worldwide, almost a third (30%) of all 
women who have been in a relationship have 
experienced physical and/or sexual violence 
by their intimate partner.1 2 Women’s lifetime 
exposure to intimate partner violence (IPV) 
is associated with myriad health outcomes. 
Systematic reviews of longitudinal data find 
that women who have been physically and/
or sexually abused by their partner at some 
point in their life are twice as likely to have an 
abortion, twice as likely to suffer from depres-
sion, and in some regions are 1.5 times more 
likely to acquire HIV compared with women 
who have not experienced IPV.2 Not surpris-
ingly, given its high prevalence and adverse 
health effects, lifetime exposure to IPV is esti-
mated to result in a high burden of disease. 
IPV is the second most common risk factor 
for disability-adjusted life years globally in 
women aged 20–24 years.3 
In our previous systematic reviews, we began 
to explore the relationships between ‘ever’ 
exposure to IPV and depressive symptoms 
and alcohol use, which revealed evidence of 
strengths and limitations of this study
 ► This is the first systematic review of cohort studies 
to measure the magnitude of the association and 
temporal direction between recent exposure to in-
timate partner violence (IPV) and health outcomes.
 ► As the review considers a broad range of outcomes, 
we identified gaps in the evidence base, including a 
need for cohort studies on recent IPV and non-com-
municable diseases such as cardiovascular disease 
hypertension and obesity, as well as post-traumatic 
stress disorder and anxiety disorder.
 ► Due to the large number of abstracts retrieved and 
the limited timeframe for the review, we were not 
able to employ double screening of abstracts; how-
ever, two researchers conducted the review of the 
final set of full-text papers, with a third reviewer 
of all full text papers where there was uncertainty 
about their inclusion.
 ► As some studies measured the outcome variable 
(either IPV or the health condition) continuous-
ly, it was not possible to combine all measures of 
effect, which limited the number of studies in the 
meta-analysis.
 ► It was not possible to quantitatively assess publica-
tion bias, as too few studies were in the meta-anal-
ysis of each health condition.
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a bidirectional association. Devries et al4 found evidence 
suggestive of an association between IPV and incident 
depressive symptoms (OR=1.97, 95% CI 1.56 to 2.48), as 
well as an association in the reverse direction between 
depressive symptoms and incident IPV (OR=1.93, 95% CI 
1.51 to 2.48). In another systematic review the authors 
found increased odds of alcohol use following IPV 
(OR=1.25, 95% CI 1.02 to 1.52) and increased odds of IPV 
following alcohol use (OR=1.27, 95% CI 1.07 to 1.52).5
Although available evidence finds important associ-
ations between IPV and a range of mental and physical 
health outcomes, the nature of the associations is not 
always clear. It is possible that exposure to IPV results in 
subsequent mental and physical health outcomes, that 
different mental and physical health conditions increase 
the risk of subsequent IPV, or that a bidirectional rela-
tionship is present.
Both IPV and some associated health outcomes, such 
as depression, anxiety and substance abuse, are chronic, 
episodic conditions, which can occur with varying 
frequency over longer time periods. Studies that measure 
lifetime exposure to IPV therefore hide the complexity 
of the relationship between IPV and mental and physical 
health outcomes. This is because estimates of ‘ever’ expo-
sure to IPV are heterogeneous, and may include anything 
from past year, before the past year and more distant 
experiences of IPV. Recent violence may lead to more 
severe health outcomes, but this may be influenced by 
duration and severity, for example, recent violence with 
no history versus recent violence experienced as part of 
ongoing historical abuse.
In the current systematic review, we build on this by 
closely examining the issue of temporality with regard 
to recent exposure to IPV and a broader range of health 
outcomes. In this paper we aim to (1) review what health 
outcomes have been examined in cohort studies of recent 
IPV (‘recent’ defined here as IPV experienced up to and 
including the last 12 months); (2) quantify the magni-
tude of the association between IPV and different health 
outcomes; and (3) examine the temporal direction of IPV 
and health outcomes.
MEthODs
A systematic review protocol was registered on PROS-
PERO on 18 March 2016 (CRD42016033372) and is avail-
able at http://www. crd. york. ac. uk/ PROSPERO/ display_ 
record. php? ID= CRD42016033372.
Literature searches
We searched Medline, EMBASE and PsycINFO from 
the first record up to 27 January 2016 (with an updated 
search conducted in November 2016). Terms for IPV were 
adapted from a previous systematic review on the preva-
lence of IPV and health outcomes, which was conducted 
for the 2010 Global Burden of Disease of IPV.1 Controlled 
vocabulary terms and text words related to longitudinal 
studies were used for each database. In order to ensure a 
wide yield of studies, terms for specific health outcomes 
were not included. An example of search strategy 
appears in online supplementary appendix 1. Reference 
list screening was undertaken for key systematic review 
papers. One study was included from a systematic review 
on IPV and perinatal mental health disorders published 
in 2017, which we identified while this paper was under 
review.
Inclusion criteria
 ► English-language publications.
 ► Longitudinal studies reporting on female partici-
pants aged 15 and over were considered. Studies were 
deemed longitudinal if either the exposure or the 
outcome was measured on at least two occasions.
 ► Studies where IPV was conceptualised as the inde-
pendent variable, or where IPV was the dependent 
variable, in order to capture any evidence of bidirec-
tional causality.
 ► All author definitions of recent IPV victimisation that 
occurred up to and including 12 months prior.
 ► All author definitions of women-related health 
outcomes that were measured on at least two occasions.
A 12-month cut-off period was chosen for recent IPV 
as this is the most commonly used period for prevalence 
estimates, it is consistent with internationally recognised 
IPV measures,6 7 and has been used in a number of inter-
vention studies for IPV.8–10
screening and data extraction
Records were initially screened by one reviewer (LJB), and 
studies not meeting the inclusion criteria were removed. 
Full-text articles were reviewed by one reviewer (LJB), 
and where there was uncertainty about the inclusion of 
an article it was referred to the senior author (KD). The 
final set of full-text articles was formally appraised by two 
reviewers (LJB and MR). Data were extracted and entered 
into an Excel spreadsheet by one reviewer (LJB). The 
study selection process including the number of studies, 
abstracts and full texts screened with reasons for exclu-
sion is summarised in the flow chart in figure 1.
Quality appraisal
The quality of each effect estimate was appraised and 
presented in table 1, which corresponds to the major 
relevant domains of potential bias in quality assessment 
tools. Consideration was given to whether definitions of 
IPV and health outcomes were based on valid, reliable 
measures. We considered whether studies controlled 
for potential confounders for two reasons. IPV and the 
health outcomes of interest commonly occur episodically 
over a period of time, and episodes of either that are 
incident over the study period may be a continuation of 
previous IPV or health outcomes. Therefore, we exam-
ined whether studies adjusted for time 1 levels (ie, at the 
beginning of the study period) of the outcome variable. 
Additionally, IPV and the health outcomes of interest are 
associated with demographic characteristics and other risk 
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factors that may explain the association between them, 
such as childhood sexual abuse. Due to the complexity 
of the potential causal pathways between IPV and the 
health outcomes, we did not specify a minimum set of 
confounders that should be adjusted for. Additionally, it 
has been noted that it is not always appropriate to adjust 
for baseline levels of an outcome variable in longitudinal 
studies. When exposures are associated with baseline 
health status, bias can arise if change in health status 
preceded baseline assessment or if the dependent vari-
able measurement is unreliable or unstable.11 However, 
we recorded whether key variables were adjusted for and 
examined the results in the light of these adjustments. 
Information was also extracted in relation to mode of 
administration of surveys, length of follow-up, number of 
waves and attrition rates.
Figure 1 Flow of studies through review. aNew systematic review published in 2017 on domestic violence in pregnancy and 
perinatal mental health disorders identified by editorial team during the peer review of our paper. IPV, intimate partner violence.
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Data analysis
Analyses were conducted by LJB and KD using Stata V.14.0. 
Study characteristics and quality are summarised descrip-
tively. Studies reported a range of effect estimates (eg, 
ORs, relative risks and correlation coefficients). Adjusted 
ORs were extracted directly from the publications, with 
the exception of one unadjusted OR which was calculated 
for a study on perceived stress, which is not one of the 
health outcomes included in the meta-analysis. Studies 
measured IPV or health outcomes in heterogeneous 
ways; therefore, the results are summarised descriptively 
for each health outcome. Where there were at least two 
estimates, random-effects meta-analysis was used to calcu-
late the pooled ORs representing associations between 
IPV occurring up to and including the last 12 months 
and various health outcomes. Higgins’ I2 statistic, which 
describes the percentage of variability in point estimates 
that is due to heterogeneity rather than sampling error,12 
was calculated. Some studies reported multiple estimates 
using overlapping definitions of IPV on the same sample 
of participants. In order to avoid double counting partic-
ipants in these studies, which can lead to falsely precise 
pooled estimates, preference was given to one estimate 
using the following algorithm implemented in the 
following sequence: (1) those derived from multivariate 
analysis, (2) where the definition of IPV closely matched 
that of the other studies in the meta-analysis, (3) where 
the reference group was unexposed to any violence and 
(4) where the estimate was most precise (ie, the smallest 
CI). This algorithm was applied to three studies. Studies 
that provided multiple estimates, but on different subsa-
mples of participants were included in the meta-analysis. 
Studies that reported other types of estimate (eg, correla-
tions coefficients, betas, risk ratios) are documented 
separately.
Patient and public involvement
Patients and the public were not involved in this system-
atic review.
rEsuLts
study characteristics
Thirty-five separate cohort studies described in 36 arti-
cles published between 2002 and 2017 with 48 863 
participants met the inclusion criteria and contained 
174 effect estimates of association between IPV and 
health outcomes. Eighteen articles were from the 
USA,13–30 three from Australia,31–33 two from New 
Zealand,34 35 three from South Africa,36–38 two from 
India,39 40 one from Puerto Rico,41 one from Spain,42 one 
from Korea,43 one from Nicaragua,44 one from Kenya,45 
one from Japan,46 one from the UK47 and one from 
Tanzania.48 Among the 35 cohort studies, 11 were house-
hold surveys,13 19 27 28 32 35 39 43 44 47 49 14 sampled participants 
from clinical settings,14 20 21 23 25 26 30 31 33 40 42 45 46 48 7 from 
schools16 17 22 24 29 36 50 and 3 from the local commu-
nity.15 38 41 Some studies were based on subpopulations of 
women, including one study (reported in two papers) of 
women receiving methadone maintenance treatment,20 21 
women attending a clinic with depressive symptoms at 
baseline,31 HIV-positive female sex workers45 and eight 
studies of pregnant women.30 33 38 40 42 46–48 Six studies 
focused on adolescents16–18 22 24 29 and one (reported in 
two papers) included women and young girls.36 37
Table 2 presents the different health outcomes measured 
in the studies, the number of studies that measure each 
health condition, the overall number of estimates that 
contribute to each health condition and the number of 
estimates that contribute to the meta-analysis.
Table 1 summarises quality issues in relation to the 36 
papers reporting on 35 separate cohort studies included 
in the review. All but 3 of the 35 cohort studies used 
recognised, validated IPV instruments or used items 
that were taken from validated instruments.40 43 47 All but 
nine studies assessed for IPV that occurred in the last 12 
months; one measured IPV in the last 3 months,39 two in 
the last 6 months,20 21 23 one in the last 4 months,29 four 
measured IPV that occurred during pregnancy,40 46–48 and 
one measured IPV during or within 12 months of preg-
nancy.30 Most of the studies assessed for physical and/or 
sexual violence from a partner, with some also including 
threats, emotional or verbal abuse. The attrition rate was 
reported or calculated in 19 studies and ranged from 
4.6%48 to 37.4%.31 The length of follow-up ranged from 
1 month46 to 10 years,49 and the number of waves ranged 
from two (multiple studies) to six.33 The smallest sample 
size was 73 adolescents29 and the largest was 1303 adult 
women.48 Table 1 presents all study estimates grouped by 
health outcome.
IPV and depressive symptoms
Thirteen studies examined the relationship between 
recent IPV and depressive symptoms,13 17 19 22–26 31 32 37 39 43 
of which one examined the association in both direc-
tions.43 Of these, nine studies provided nine estimates of 
association between IPV and subsequent depressive symp-
toms.13 19 22 23 25 31 32 39 43 Eight of these estimates showed 
a positive direction of association between experience of 
IPV and subsequent depressive symptoms.9 13 19 22 23 31 32 39 
Of the nine estimates of the association between IPV and 
subsequent depression, all but two reached statistical 
significance.25 39 Five studies provided five estimates of 
association between depression and subsequent IPV, all of 
which showed a positive and statistically significant rela-
tionship.17 24 26 37 43
We were able to include seven estimates reporting 
binary IPV measures and binary depressive symptoms 
or disorder measures in the meta-analysis. For IPV and 
subsequent depressive symptoms or disorder, the pooled 
OR from five estimates13 25 31 32 39 was 1.76 (95% CI 1.26 to 
2.44, I2=37.5%, p=0.172). Two estimates17 37 were included 
in the meta-analysis of the relationship between depres-
sive symptoms and subsequent IPV, resulting in a pooled 
OR of 1.72 (95% CI 1.28 to 2.31, I2=0.0%, p=0.752). One 
study, not included in the meta-analysis, examined the 
 o
n
 3 August 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019995 on 28 July 2018. Downloaded from 
12 Bacchus LJ, et al. BMJ Open 2018;8:e019995. doi:10.1136/bmjopen-2017-019995
Open access 
bidirectional relationship between IPV and depression.43 
A Korean study of married women found that IPV at 
wave 1 was positively associated with the depression level 
at wave 1 (beta=0.030, SE=0.03, p<0.001), but negatively 
associated with the growth rate of depression over the 
study period (beta=−0.03, SE=0.01, p=0.004). IPV expe-
rienced at wave 4 was associated with a larger growth rate 
of depression in the model (beta=3.34, SE=0.61, p<0.001) 
and the experience of IPV at wave 1 (beta=0.68, SE=0.11, 
p<0.001) (see figure 2).
Depression measurement
Of the nine studies that measured IPV and subsequent 
depressive symptoms, one measured depressive symp-
toms occurring in the past 12 months,25 one in the last 
2 weeks,31 five in the last week,13 19 22 32 43 one ‘current’39 
and one did not specify a time period.23 Of the five 
studies that measured depressive symptoms and subse-
quent IPV, three measured depressive symptoms in the 
past week,17 37 43 one in the past 6 months24 and one did 
not specify a time period.26
All but one of the studies used screening questionnaires 
that measured depressive symptoms as opposed to diag-
nostic tools. Of the 13 studies, eight used the Center for 
Epidemiological Studies-Depression Scale,13 17 19 22 23 32 37 43 
one study used the WHO International Classification of 
Diseases, 10th Revision,39 one used the Composite Inter-
national Diagnostic Interview-Short Form (CIDI-SF),25 
one used the Patient Health Questionnaire,31 one used 
the Beck Depression Inventory (BDI)26 and one used a 
scale from Kandel and Davies.24
Common risk factors/confounding
Of the nine studies that measured IPV and subsequent 
depressive symptoms and disorder, all but one controlled 
for time 1 levels of depression. Chowdhary and Patel39 
excluded women with baseline depressive disorder in 
their analysis, but this may have resulted in the exclusion 
of cases of IPV that preceded depressive symptoms at base-
line and the remaining cases may not have been represen-
tative of women experiencing IPV. All but one of the five 
studies that measured depressive symptoms and later IPV 
controlled for time 1 levels of IPV.26 Of the 13 studies, all 
but 2 controlled for sociodemographic factors.26 39 Other 
confounders were not comprehensively controlled for. 
Two studies controlled for childhood physical and/or 
sexual abuse17 31 and two for alcohol use,24 37 of which one 
also controlled for childhood adversity which measured 
emotional and physical neglect, and physical and sexual 
abuse.37 There were no discernible differences in effect 
estimates regardless of which confounders were adjusted 
for, and studies found similar directions and varying 
magnitudes of association.
IPV and postpartum depressive symptoms
Eight studies provided eight estimates of association 
between IPV and subsequent postpartum depressive 
symptoms.30 33 38 40 42 46–48 All eight estimates showed a 
positive direction of association between IPV and subse-
quent postpartum depressive symptoms, with all but 
one of the estimates reaching statistical significance.46 
Seven estimates from five studies were included in 
the meta-analysis of the relationship between IPV and 
Table 2 Health outcomes/health risk behaviours measured in the 35 studies and the number of estimates
Health outcome Studies and estimates (n), references
Estimates in the meta-
analysis (n)
Depression 13 studies13 17 19 22–26 31 32 37 39 43; 13 estimates 7
Postpartum depression 8 studies30 33 38 40 42 46–48; 11 estimates 7
Suicide attempts 2 studies22 39; 2 estimates NA
Perceived stress 2 studies27 44; 3 estimates NA
General anxiety 1 study25; 1 estimate NA
Self-perceived health status 1 study42; 1 estimate NA
Hard drug use 4 studies14 21 28 41; 6 estimates 5
Marijuana use 4 studies14 16 21 28; 7 estimates 5
Other combinations of illicit drug/alcohol use 4 studies14 16 22 23; 5 estimates NA
Alcohol use 10 studies14–16 19 21 27–29 35 49; 18 estimates 9
HIV infection 2 studies20 36; 3 estimates NA
Sexually transmitted infections 3 studies20 39 45; 2 estimates NA
Sexual risk behaviours 3 studies18 20 45; 8 estimates NA
Abnormal vaginal discharge 1 study39; 3 estimates NA
Dysuria 1 study39; 3 estimates NA
Lower abdominal pain 1 study39; 3 estimates NA
Dyspareunia 1 study39; 3 estimates NA
NA, not applicable as study estimates were continuous and could not be included in a meta-analysis.
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subsequent postpartum depression,30 33 42 47 48 resulting 
in a pooled OR of 2.19 (95% CI 1.39 to 3.45). This was 
heterogeneous (I2=79.8%, p=0.000). One of the studies 
examined the bidirectional relationship and found 
that depression symptom severity was associated with 
a greater risk of subsequent IPV.38 Each 5-point differ-
ence in the Edinburgh Postnatal Depression Scale 
(EPDS) was associated with a 0.9-point to 2.3-point 
difference in subsequent IPV risk (beta=0.054, 95% CI 
0.030 to 0.079).
Postpartum depression measurement
Of the eight studies that measured IPV and subsequent 
depressive symptoms, one measured depressive symptoms 
occurring in the past 12 months,42 six studies measured 
depressive symptoms in the last week33 38 40 46–48 and one 
study did not specify the time period.30 One study measured 
postpartum depression in the last week and subsequent 
IPV.38 Of the eight studies, six used the EPDS,33 38 40 42 47 48 
one used the Hospital Anxiety and Depression Scale46 and 
one used the BDI.30
Common risk factors/confounding
Six of the eight studies that examined IPV and subse-
quent postpartum depression controlled for time 1 levels 
of depressive symptoms.30 33 38 42 46 47 One study did not 
control for time 1 levels of depressive symptoms as it was 
not significant in the bivariate analysis.48 Five studies 
Figure 2 Forest plot estimates of the association between intimate partner violence and depression. Woolhouse 
et al33 estimates are based on different subsamples and are mutually exclusive. Meta-analysis with depression as the 
dependent variable was also undertaken excluding the Chowdhary and Patel39 study which removes women with baseline 
depressive disorder from the analysis, but it did not materially change the overall pooled estimate (OR=1.85, 95% CI 1.35 to 
2.49, I2=35.1%, p=0.202).
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controlled for sociodemographic factors.33 38 42 46 48 One 
study controlled for HIV serostatus38 and one controlled 
for HIV/AIDS diagnosis.48
IPV and alcohol use
Ten studies examined the relationship between recent IPV 
and alcohol use. Of these, eight studies provided 15 esti-
mates of association between IPV and subsequent alcohol 
use.14–16 19 21 27–29 35 49 All but one of these 15 estimates 
showed a positive direction of association between IPV 
and subsequent alcohol use,15 with two studies providing 
4 estimates which reached statistical significance.27 49 
Three studies21 28 29 provided three estimates showing a 
positive direction of association between alcohol use and 
subsequent IPV, of which one was statistically significant.29
For IPV and later alcohol use, the pooled OR from six 
estimates provided by three studies16 21 35 was 1.19 (95% 
CI 0.91 to 1.55, I2=0.0%, p=0.523). Three estimates from 
two studies21 28 were included in the meta-analysis of the 
relationship between alcohol use and subsequent IPV, 
resulting in a pooled OR of 1.11 (95% CI 0.91 to 1.35, 
I2=0.0%, p=0.672).
Alcohol use measurement
Of the eight studies that measured IPV and subsequent 
alcohol use, five measured alcohol use in the last 12 
months,15 16 27 35 49 two in the last 6 months14 21 and one 
in the last 30 days.19 Of the three studies that measured 
alcohol use and subsequent IPV, one measured alcohol 
user in the last 12 months,28 one in the last 4 months29 
and one in the last 6 months.21 Alcohol consumption was 
measured in a variety of ways. Of the 10 studies, one assessed 
alcohol abuse or dependence using the CIDI-SF,49 four 
measured binge drinking which was based on the number 
of alcoholic drinks consumed on one occasion,14 16 21 35 
three measured heavy drinking which was assessed using 
a combined quantity–frequency measure,27–29 one used 
the Alcohol Dependence Scale and the Michigan Alcohol 
Screening Test,15 and one used the National Survey of 
Alcohol and Drug Abuse.19
Common risk factors/confounding
Of the eight studies that measured IPV and subsequent 
alcohol use, only four adjusted for time 1 levels of alcohol 
use.14–16 27 Of the three studies that examined the asso-
ciation between alcohol use and subsequent IPV, all but 
one adjusted for time 1 levels of IPV.21 Of the 10 studies, 7 
controlled for sociodemographic factors.14–16 21 27 28 35 Two 
studies adjusted for a history of trauma. El-Bassel et al21 
controlled for childhood sexual abuse, post-traumatic 
stress disorder, multiple concurrent partners and 
frequency of condom use. Gilbert et al14 also controlled for 
childhood sexual abuse, as well as psychological distress, 
coping strategies, the partner’s illicit drug use and binge 
drinking and sexual relationship power. Regardless of 
the confounders controlled for, all but one study found 
a positive direction of association and reported varying 
magnitudes of association.27
IPV and hard drug use (crack, cocaine, heroin)
Four studies examined the relationship between recent 
IPV and hard drug use,14 21 28 41 of which one reported an 
association in both directions.21 Two studies provided two 
estimates of IPV and subsequent hard drug use, both of 
which showed a positive direction of association, although 
only one was statistically significant.21 41 The pooled OR 
from these studies was 2.05 (95% CI 1.19 to 3.52, I2=0.0%, 
p=0.948). Three studies provided four estimates of hard 
drug use and subsequent IPV, which showed a positive 
direction of association and three of these were statis-
tically significant.14 21 28 Three of these estimates were 
included in the meta-analysis, resulting in a pooled OR of 
2.20 (95% CI 1.52 to 3.17, I2=0.0%, p=0.455).
Hard drug use measurement
Of the two studies that measured IPV and subsequent 
hard drug use, one study measured drug use in the last 
12 months41 and the other in the last 6 months.21 Of the 
three studies that measured hard drug use and subse-
quent IPV, one assessed use in the last 12 months28 and 
two in the last 6 months.14 21 Of the four studies, two used 
the Drug Use and Risk Behaviour Questionnaire14 21 and 
two asked about use of specific hard drugs including 
crack, cocaine and heroin.28 41 Of the latter, one of the 
studies used two methods for assessing hard drug use at 
each wave, including self-report information only and 
combined self-report and toxicological information.41
Common risk factors/confounding
Of the two studies that measured IPV and subsequent 
hard drug use, one controlled for time 1 levels of hard 
drug use.41 Of the three studies that measured hard drug 
use and subsequent IPV, two controlled for time 1 levels of 
IPV.14 28 All four studies controlled for sociodemographic 
factors. El-Bassel et al21 controlled for childhood sexual 
abuse, post-traumatic stress disorder, multiple concurrent 
partners and frequency of condom use. Gilbert et al14 
controlled for childhood sexual abuse, psychological 
distress, coping strategies, the partner’s illicit drug use 
and binge drinking and sexual relationship power.
IPV and marijuana use
Four studies examined the relationship between recent 
IPV and marijuana use,14 16 21 28 of which two studies 
reported an association in both directions.14 21 Three 
studies provided three estimates of IPV and subsequent 
marijuana use, all showing a positive direction of associ-
ation, although none were statistically significant.14 16 21 
Two of these studies were included in the meta-anal-
ysis, resulting in a pooled OR of 1.52 (95% CI 1.04 to 
2.24, I2=5.4%, p=0.304). Three studies provided four 
estimates of marijuana use and subsequent IPV,14 21 28 of 
which one showed a positive and statistically significant 
relationship. Three of these estimates were included in 
the meta-analysis, resulting in a pooled OR of 1.96 (95% 
CI 0.8 to 4.83). This was heterogeneous (I2=85.4%, 
p=0.001).
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Marijuana use measurement
Of the four studies, two measured marijuana use in the 
last 12 months16 28 and two in the last 6 months.14 21 All 
studies used self-report information to assess for mari-
juana use.
Common risk factors/confounding
Of the three studies that measured IPV and subsequent 
marijuana use, two controlled for time levels of marijuana 
use.14 16 Of the three studies that measured marijuana 
use and subsequent IPV, two controlled for time levels of 
IPV.14 28 All the studies controlled for sociodemographic 
factors. El-Bassel et al21 controlled for childhood sexual 
abuse, post-traumatic stress disorder, multiple concurrent 
partners and frequency of condom use. Gilbert et al14 
controlled for childhood sexual abuse, psychological 
distress, coping strategies, the partner’s illicit drug use 
and binge drinking and sexual relationship power.
IPV and stIs (excluding hIV)
Three studies provided three estimates of the association 
between recent IPV and subsequent sexually transmitted 
infections (STIs),20 39 45 of which one showed a positive 
and statistically significant relationship.39 The meta-anal-
ysis of two of these studies20 39 resulted in a pooled OR of 
1.10 (95% CI 0.56 to 2.18, I2=35.5%, p=0.214).
STI measurement
One study assessed for STIs (chlamydia, gonorrhoea or 
trichomoniasis) within the last 3 months using biolog-
ical measures,39 another relied on self-report to assess 
for STIs at the last wave,20 and the third study assessed 
women quarterly for gonorrhoea, chlamydia or trichomo-
niasis using biological measures.45
Common risk factors/confounding
All the studies controlled for sociodemographic factors. 
El-Bassel et al’s study21 of women attending a methadone 
maintenance clinic adjusted for time 1 HIV risk factors 
(ie, frequency of condom use, frequency of requesting 
condom use, having unprotected anal sex, exchanging 
sex for drugs, being HIV-positive and having had an STI), 
as well as drug and alcohol use. Chowdhary and Patel39 
removed women with an STI at time 1 from the analysis. 
However, this would likely have introduced bias in the 
resulting cases, as it would have excluded women with 
IPV that preceded the acquisition of an STI at baseline. 
Wilson et al’s45 study of HIV-positive sex workers did not 
control for time 1 sexual risk behaviours, although it 
did control for a lifetime history of sexual violence since 
the age of 15 by someone other than the index partner. 
Figure 3 presents the forest plots for alcohol use, hard 
drug use, marijuana use and STIs.
DIsCussIOn
summary of main findings
Our review identified cohort studies that examined the 
relationship between recent IPV (ie, IPV occurring up 
to and including the last 12 months) and depression, 
postpartum depression, alcohol use, hard drug use, 
marijuana use and STIs. Although a few other health or 
health-related outcomes were identified (ie, sexual risk 
behaviours, HIV infection, general anxiety, perceived 
stress and gynaecological problems), these could not be 
included in a meta-analysis because there was only one 
estimate. We found evidence consistent with a bidirec-
tional relationship between recent IPV and depressive 
symptoms. Recent IPV was also associated with increased 
symptoms of postpartum depression. There was some 
evidence of a bidirectional relationship between recent 
IPV and hard drug use, and IPV and subsequent mari-
juana use, although there were a limited number of 
studies. There was no evidence of an association between 
recent IPV and alcohol or STIs, although the evidence 
was weak with few studies and inconsistent measurement 
of alcohol and STIs.
Although the search strategy did not limit the types of 
health outcomes identified, the review found no cohort 
studies for recent IPV exposure and non-communicable 
diseases such as cardiovascular disease, hypertension and 
obesity. Nor did we find longitudinal evidence for recent 
experience of IPV and post-traumatic stress disorder or 
anxiety disorder. There is limited evidence from cross-sec-
tional data that lifetime IPV increases the risk of cardio-
vascular disease.51 Cohort studies measuring history of 
IPV have reported an association with increased body 
mass index,52 increased risk for cardiovascular disease53 
and hypertension.54 Physiological mechanisms may 
explain the association between IPV and some adverse 
health outcomes through complex neural, neuroendo-
crine and immune responses to acute and chronic stress. 
For example, sustained and acute elevated stress levels 
have been linked to cardiovascular disease, hyperten-
sion, gastrointestinal disorders and chronic pain. When 
exposed to prolonged or acute stress, areas of the brain 
(eg, hippocampus, amygdala and prefrontal cortex) 
undergo structural changes that can impact on mental 
and cognitive functioning, which can lead to mental 
disorders.55
We found evidence consistent with a bidirectional rela-
tionship between recent experience of IPV and depres-
sive symptoms. The magnitude of the association in either 
direction is similar to that reported in our previous review 
of ‘ever’ IPV and depressive symptoms,4 although there 
were fewer estimates in our meta-analysis of recent IPV 
and depressive symptoms.
All the studies on postpartum depressive symptoms 
conceptualised IPV as the dependent variable and 
there was evidence that recent experience of IPV or IPV 
during pregnancy increased symptoms of subsequent 
postpartum depression, although there was substantial 
heterogeneity. The magnitude of the association was 
slightly lower (OR=2.19, 95% CI 1.39 to 3.45) compared 
with Howard et al,56 who reported a threefold increase in 
the levels of depressive symptoms in the postnatal period 
after having experienced IPV during pregnancy (OR=3.1, 
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95% CI 2.7 to 3.6). However, the authors state that study 
heterogeneity and lack of data on baseline symptoms 
prevented conclusions on temporality. In addition, we 
excluded one study that was included in the Howard et 
al56 review as it measures postnatal depressive symptoms 
using the EPDS at the final wave, but assesses common 
Figure 3 Forest plot estimates of the association between intimate partner violence and alcohol use, hard drug use, marijuana 
use and sexually transmitted infections (STIs). Estimates from Gao et al35 and Testa et al28 are based on different subsamples 
and are mutually exclusive.
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mental health disorders during pregnancy with the 
Self-Reporting Questionnaire-20.57 A recently published 
systematic review explored studies of IPV during preg-
nancy and perinatal mental disorders in low-income and 
middle income countries. However, most of the studies 
were cross-sectional and considered partner violence 
experienced during pregnancy. Furthermore, estimates 
were not pooled in a meta-analysis.58
There was no evidence of an association between recent 
IPV and alcohol use in either direction. This might be 
because there were fewer estimates in the meta-analysis 
of recent IPV, and measurement of problematic alcohol 
use was conceptualised in a number of different ways, for 
example, binge drinking, heavy episodic drinking and 
high-risk alcohol use, which may have diluted the effect. 
None of the estimates in the meta-analysis measured 
alcohol use disorder. Furthermore, not all the estimates 
in the meta-analysis controlled for time 1 levels of alcohol 
use, and only one included the perpetrator's alcohol 
use, which may be related to IPV and/or the woman’s 
drinking behaviour. This finding is in contrast to our 
previous review of ‘ever’ IPV and alcohol use, which did 
find evidence consistent with a bidirectional relation-
ship.5 Although the pooled estimates in both reviews are 
based on studies that assess binge drinking, the Devries 
et al5 review includes estimates of IPV that occurred in the 
distant past (ie, before the last 12 months).
Our review found evidence consistent with a bidi-
rectional relationship between recent IPV and hard 
drug use. However, this finding should be treated with 
caution as there were very few studies overall, and one of 
the studies was based on a sample of women attending 
a methadone maintenance clinic. For marijuana use, 
there were few studies, but the evidence suggests that IPV 
predicts subsequent marijuana use. Pooled estimates did 
not support that marijuana use predicts subsequent IPV, 
although estimates were heterogeneous. The evidence 
for recent IPV and STI infection was in conflicting direc-
tions and there were only two estimates. Our review adds 
to previous systematic reviews as it focuses on longitudinal 
studies that measure recent experiences of IPV. Further-
more it includes a broader range of health or health-re-
lated outcomes and explores bidirectionality. The review 
also highlights that longitudinal studies on recent IPV are 
lacking for important health outcomes that are known to 
be associated with partner violence.
Limitations of the review
To our knowledge, this is the first systematic review of 
cohort studies to measure the magnitude of the asso-
ciation between recent exposure to IPV and health 
outcomes/health risk behaviours. Although we conducted 
an extensive search of the global literature, the review 
has a number of limitations. Due to the large number 
of abstracts retrieved and the limited timeframe for the 
review, we were not able to employ double screening of 
abstracts. Citation tracking was not undertaken, although 
we conducted reference list screening of key systematic 
review papers. However, two researchers reviewed the 
final set of included papers, with a third reviewer of all 
full text papers where there was uncertainty about their 
inclusion. One researcher was responsible for extracting 
data from included papers. As some studies measured the 
outcome variable (either IPV or the health condition) 
continuously, it was not possible to combine all measures 
of effect, which limited the number of studies in the 
meta-analysis. However, we comment on the direction of 
the association of studies that were not included in the 
meta-analysis in the Results section for each health condi-
tion. It was not possible to quantitatively assess publica-
tion bias as too few studies were in the meta-analysis of 
each health condition.
sources of bias and limitations of included studies
One of the main limitations of the included studies relates 
to the lack of consistency in controlling for key potential 
confounders. With regard to studies on depression, hard 
drug use and marijuana use, most controlled for time 1 
levels of the health condition or IPV (where IPV was the 
dependent variable). Far fewer of the estimates on IPV 
and later alcohol use and IPV and STI controlled for time 
1 levels of the health outcome.
With regard to the studies on depressive symptoms, 
only two controlled for early childhood trauma (ie, child-
hood sexual and/or physical abuse) and two controlled 
for alcohol use, even though both are known to increase 
the risk for depression.59 60 This makes it difficult to rule 
them out as potential contributors to the causation of the 
outcomes. Nevertheless, we found that studies showed a 
positive direction of association, regardless of which vari-
ables were adjusted for, and there was no clear pattern of 
differing magnitude of association that indicated the rela-
tionship between IPV and depressive symptoms was not 
likely to be entirely accounted for by shared risk factors.
Little is known about the potential causal mecha-
nisms between depression and subsequent IPV. However, 
women who are depressed may experience symptoms 
(eg, lethargy and withdrawal) that impact their capacity 
for engaging in self-care behaviours including help-
seeking and contact with healthcare providers that could 
enable them to extricate themselves from the relation-
ship. It is also plausible that earlier, perhaps unmeasured 
experiences of violence, such as childhood sexual abuse 
and trauma, are causing depression and later IPV, or that 
depression is mediating the relationship between child-
hood sexual abuse and later IPV. A path analysis with 
cross-sectional data supports this hypothesis,60 but few 
longitudinal studies have explored these relationships.
Only two studies on alcohol use controlled for child-
hood sexual abuse and one controlled for the partner’s 
level of alcohol use, both of which are potential causes of 
women’s alcohol use. It has been suggested that women 
who drink heavily are more likely to have a partner who 
drinks heavily, which can increase their risk of IPV because 
heavy alcohol use by men is associated with IPV perpetra-
tion.61 This can occur because people tend to choose a 
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partner with similar drinking patterns to themselves or 
through the influence of their partner’s drinking patterns 
and expectations.62 Research also suggests that the part-
ner’s or the woman’s drinking may fuel conflict in the 
relationship. A nationally representative study from the 
USA found that couples with similar drinking patterns 
(eg, both abstinent or both binge drinkers) were less 
likely to experience IPV in their relationship compared 
with those with discordant drinking habits.63 This implies 
that relationship conflict may result in IPV, as opposed 
to alcohol use alone because high alcohol use would be 
more predictive than discordant use. Alcohol use was 
measured in a variety of ways, with most assessing binge 
drinking or heavy drinking and only two studies measuring 
alcohol dependence. Although heavy alcohol consump-
tion increases the risk for disease, injury and premature 
death,64 65 the adverse consequences may vary consider-
ably between people who sporadically drink heavily and 
those who develop an alcohol use disorder. Although the 
evidence points to a bidirectional relationship between 
IPV and hard drug use and IPV and marijuana use, 
there were few estimates. Women may self-medicate 
with alcohol, tobacco or drugs in an attempt to cope 
with the trauma and stress of living in an abusive rela-
tionship, which in themselves are important risk factors 
for poor health. However, alcohol or substance abuse by 
the abuser or the woman has also been identified as a 
trigger to violent episodes or a factor that contributes to 
more severe violence.66 The evidence for the association 
between recent IPV and STIs is uncertain.
It was not possible to examine whether the duration 
or severity of the violence influenced the relationship 
between IPV and health. Studies conceptualised violence 
as physical, sexual, verbal or emotional (or psycholog-
ical), with most using a combination of types of violence. 
Only one study provided estimates of minor and severe 
violence. Studies reported the timeframe in which the 
violence occurred, but not the duration.
The majority of the studies were from high-income 
countries, most notably the USA, and only eight studies 
were from middle-income countries, where it is known 
that the prevalence of past-year IPV is higher. Six of 
the studies were of adolescents, again mostly in high-in-
come countries, where these were likely to be in dating 
relationships with no cohabitation. One study included 
young girls and women. Experiences of IPV in adult and 
adolescent relationships may be qualitatively different, in 
that there is a lower likelihood of experiencing system-
atic and chronic violence in dating relationships.67 About 
a third of the studies were drawn from clinical settings, 
schools or were taken from subpopulations and there-
fore subject to bias (eg, HIV-positive sex workers, women 
with depressive symptoms and women on methadone 
maintenance). More population-based cohort studies are 
needed in order to generalise the findings. Most studies 
measured physical violence and some modelled exposure 
to physical and sexual and other forms of violence sepa-
rately. However, other forms of violence (eg, emotional 
abuse, threats) may also be associated with some of the 
health outcomes. Most studies constructed the reference 
categories for IPV as binary opposites, meaning that 
some participants in the reference group may have been 
exposed to other forms of IPV that were not measured or 
modelled. This can bias the effect estimates towards the 
null and underestimate the magnitude of the association 
between recent IPV and health outcomes. Some studies 
included only women who were in a relationship for all 
waves of data collection. However, research shows that the 
prevalence of IPV is higher among women who are no 
longer with abuser compared with those currently in a 
relationship,68 and excluding these women may dilute the 
association between IPV and health outcomes.
IMPLICAtIOns
The evidence on the association between exposure to IPV 
and mental and physical health outcomes has important 
implications for the delivery of interventions and services. 
IPV against women has received increasing attention 
from public health experts globally.2 The results of this 
review indicate that healthcare providers and specialist 
IPV organisations should be aware of the bidirectional 
relationship between recent IPV and depression. Women 
with depression may be at risk of IPV, including IPV that 
is ongoing, and services, particularly healthcare, should 
be trained to enquire about IPV experiences and respond 
and refer appropriately. Little is known about what 
pattern of exposure to IPV is more strongly associated 
with different health outcomes. In order to establish these 
connections, longitudinal studies of IPV and health are 
needed that distinguish recent violence with no history 
from recent violence that is part of ongoing abuse and 
historical violence that no longer occurs. Other factors 
that are known to mediate the relationship, such as the 
duration and severity of IPV, childhood physical and 
sexual abuse, poverty-related stress, and risk behaviours 
such as alcohol and substance abuse, should be carefully 
considered in analyses.
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